RxDoctor Payments Data

Lisa Churchill

Family · Summerville, SCNPI 1295196947

Payments from drug & device makers

$583in general payments, 2019–2025

Across 25 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$186
  • AbbVie$99
  • Exact Sciences$79
  • Dexcom, Inc.$57
  • Pfizer$42
  • Sanofi-aventis U.S. LLC$23
  • plus $97 from 5 others

What the payments were for

  • Food & beverage$583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$583 in reported general payments places this provider in the 55th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$27,131
Medicare patients
168
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide20$23,814
EliquisApixaban14$22,141
Arnuity ElliptaFluticasone Furoate14$5,168
Albuterol Sulfate HfaAlbuterol Sulfate56$1,580
SynthroidLevothyroxine Sodium20$1,553
Gabapentin59$1,140
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid13$962
Atorvastatin Calcium98$853
Levothyroxine Sodium83$630
Potassium Chloride22$600
Pregabalin17$559
Omeprazole56$550
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine16$550
Losartan Potassium68$542
Duloxetine Hcl27$517

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$22,14114 claims
AbbVieSynthroid$99$1,55320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,248 family providers in South Carolina.

Other family in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →